Background {#Sec1}
==========

Although *Staphylococcus* are commensals of the skin, mucous membranes, alimentary and urogenital tracts of a diverse group of mammals and birds, they have been implicated in clinical infections of humans and animals \[[@CR1]--[@CR3]\]. Transmission of *Staphylococcus* between animals and humans are known to occur \[[@CR1], [@CR4]\]. Cats have been reported as carriers of both Coagulase positive (CoPS) and coagulase negative *Staphylococc*us species (CoNS) \[[@CR2], [@CR3], [@CR5]--[@CR7]\]. However, coagulase positive *Staphylococcus* species infections seem to be more prominent in feline medicine than CoNS infections \[[@CR1]\]. Among the CoPS species in cats, *S. pseudintermedius* are the most common followed by *S. aureus* \[[@CR5], [@CR8]\]. These infections have been associated with pyoderma, postoperative wound infections and otitis \[[@CR9]\]. In addition, *S. felis*, is a cause of urinary tract infections \[[@CR10]\].

Although resistance to β-lactam antimicrobials among *Staphylococcus* isolates from cats has been reported \[[@CR6], [@CR8]\], other antimicrobial agents such as gentamycin, enrofloxacin and doxycycline have been reported to be effective against *Staphylococcus* infections in cats \[[@CR5], [@CR11], [@CR12]\]. However, information on the proportion of antimicrobial resistant isolates and resistance patterns of *Staphylococcus* species in clinical cases of cats in developing economies in general and South Africa in particular is very limited. Therefore, the objective of this study was to investigate the proportion of antimicrobial resistant isolates and resistance patterns among *Staphylococcus* species isolates from cat samples submitted to a veterinary academic hospital in South Africa between 2007 and 2012.

Methods {#Sec2}
=======

Data collection {#Sec3}
---------------

Data containing records of cat samples submitted to the University of Pretoria Bacteriology Laboratory at the Veterinary Teaching Hospital in South Africa between January 2007 and December 2012 for routine diagnostic tests were evaluated. The following variables were captured: breed, age, sex, specimen type, staphylococcus species isolated, antimicrobial included in the antimicrobial susceptibility test panel and the susceptibility profile of the isolates.

Staphylococcus identification and antimicrobial susceptibility testing {#Sec4}
----------------------------------------------------------------------

Culture of samples was done using sheep blood agar incubated at 37 °C for at least 24 h. All media used were quality controlled using *S. aureus* ATCC 25923. Suspected *Staphylococcus* colonies were identified based on phenotypic characteristics including colony characteristics, catalase, D-mannitol, maltose, deoxyribonuclease (DNase) tests, polymyxin-B and Gram-staining as described by Quinn \[[@CR13]\]. *S. intermedius* and *S. delphini* were classified as *S. intermedius* group (SIG) as described by Sasaki et al. \[[@CR14]\].

Isolates were subjected to antimicrobial susceptibility testing against a panel of 15 drugs using the disc diffusion method (discs supplied by Oxoid) \[[@CR15]\]. Included in the panel were the following drugs: 30 μg amikacin (AK), 30 μg doxycycline (DOX30), 5 μg enrofloxacin (ENR), 10 μg gentamicin (CN), 10 μg penicillin G (P), 25 μg sulpha-trimethroprim (SXT), 30 μg chloramphenicol (C), 30 μg cephalothin/lexin (KF), 30 μg kanamycin (K), 2 μg clindamycin/lincomycin (MY), 100 μg lincospectin (Espectinomycine-lincomycine) (LS100), 5 μg orbifloxacin (OBX5), 20/10 μg synulox (Amoxicillin-Clavulanic acid) (AMC20/10) and 15 μg tylosin (TY). The results, based on the diameter of the inhibition zones, were classified as sensitive, intermediate or resistant in accordance with the Clinical and Laboratory Standards Institute \[[@CR15]\]. For the purposes of the study, intermediate susceptibility was considered as susceptible. Multidrug resistance (MDR) was defined as resistance to at least one antimicrobial agent in three or more antimicrobial categories \[[@CR16]\].

Data analysis {#Sec5}
-------------

All the statistical analyses were performed using SAS 9.4 (SAS Institute Inc., Cary, NC, USA) statistical package. The dataset was assessed for missing data and inconsistencies such as improbable values. Shapiro-Wilk test of normality was used for evaluation of distributions of age that was found to be non-normally distributed and hence median and interquartile ranges were reported. Age was also categorised into two categories: \<2 years and ≥2 years. The frequencies and proportions of all categorical variables were calculated and presented in a table. Associations between antimicrobial resistance of *Staphylococcus* spp. isolates and a number of host factors (breed, age, sex, specimen type) and other categorical variables were assessed using the Chi-square and Fisher's Exact tests. Statistical significant was assessed using a critical *p*-value of 0.05. The variables specimen type and breed had too many categories to include in the model in their original form and hence they were re-coded (Table [1](#Tab1){ref-type="table"}).Table 1Distribution of *Staphylococcus* isolates among cat specimens tested at an academic veterinary hospital laboratory, 2007--2012Number of cats tested*Staphylococcus* positiveVariableCategoryFrequencyPercentFrequencyPercentBreed (*n* = 212)Domestic Short Hair13262.32418.2Persian219.9419.1Siamese157.116.7Domestic Long Hair125.7325.0All others3215.1618.8Sex (*n* = 205)Male12259.51713.9Female8340.52024.1Specimen type (*n* = 215)Urine9544.233.2Ear canal swab2913.51034.5Skin188.41161.1All others7334.01419.2Age (*n* = 216)≥2 years12356.92117.1\<2 years9343.11718.3

Univariable and multivariable models {#Sec6}
------------------------------------

Investigation of the predictors of *Staphylococcus* spp. infections was done in two steps. In the first step, univariable logistic regression model was fit to assess the relationships between sex, age, specimen type and breed, and the outcome variable, *Staphylococcus* status. The potential predictors of *Staphylococcus* spp. infection at this stage were identified using a relaxed α ≤ 0.20. Thus variables with *p* ≤ 0.20 in the univariable model were considered for inclusion in the multivariable model in the 2nd step. Therefore, the 2nd step involved fitting a multivariable logistic regression model using manual backwards selection method with the significance set at α ≤ 0.05.

Confounding was assessed by comparing the change in model coefficients with and without the suspected confounders. If the removal of a suspected confounding variable resulted in a 20% or greater change in another model coefficient, the removed variable was considered a confounder and retained in the model regardless of its statistical significance. In addition, two-way interaction terms between variable in the final main effects model were assessed.

Odds ratios (ORs) and their 95% confidence intervals were computed for variables included in the final model. The differences between categories of statistically significant predictors for *Staphylococcus* spp. were also assessed by changing the reference categories of the predictors. Hosmer-Lemeshow goodness-of-fit test was used to assess model fit.

Results {#Sec7}
=======

A total of 216 samples were submitted to the bacteriology lab during the study period, of which, 17.6% (38/216) tested positive for *Staphylococcus* spp. each of which had single isolates (i.e. no mixed infections were identified).The majority of samples tested were urine (44.2%, 95/215), followed by ear canal swab (13.5%, 29/215) and skin samples (8.4%, 18/215). Significantly (*p* = 0.0065) more samples originated from males (59.5%, 122/205) than female cats (40.5, 83/205). Similarly, a significantly (*p* = 0.0412) higher proportion of samples came from cats ≥2 years (56.9%, 123/216) compared to cats \<2 years (43.1%, 93/216). The majority of samples were obtained from the domestic short hair breed (DSH) (62.3%, 132/212), followed by Persian breed (9.9%, 21/212) (Table [1](#Tab1){ref-type="table"}).

*Staphylococcus* species were isolated from several cat breeds including domestic long hair (25.0% 3/12), domestic short hair (18.2%, 24/132) and persian breed (19.1%, 4/21). Skin samples yielded the highest (61.1%,11/18) percentage of *staphylococcus* isolates followed by ear swabs (34.5%,10/29).

Significantly (*p* = 0.02) more CoPS (11.1%, 24/216) were isolated compared to CoNS (1.9%, 4/216). Among the CoPS, *S. intermedius* group was most predominant (7.9%, 17/216) followed by *S. aureus* (3,2%, 7/216). Equal percentage of *S. felis* (0.9%, 2/216) and *S. simulans* (0.9%; 2/216) were observed among the CoNS. Five percent (4.6%, 10/216) of the *Staphylococcus* isolates identified were not characterized (Table [2](#Tab2){ref-type="table"}).Table 2Distribution of *Staphylococcus* species isolated from clinical specimens from cats presented at an academic veterinary hospital between 2007 and 2012 (*n* = 216)IsolateFrequencyPercent (%)CoPS *n* = 24 (11.1%)*S. intermedius* group (SIG)177.9*S. aureus*73.2CoNS *n* = 4 (1.9%)*S. felis*20.9*S. simulans*20.9Unspeciated*S*. spp.104.6Negative17282.4Total216100

*Staphylococcus* isolates exhibited relatively high levels of resistance towards ampicillin (32.4%, 12/26), penicillin-G (29.0%, 11/27), clindamycin (34.2%,13/25) and lincospectin (31.6%, 12/26) (Table [3](#Tab3){ref-type="table"}). Overall, 63.2% (24/38) of *Staphylococcus* spp. were resistant to at least one antimicrobial agent and 21.1% (8/38) were multidrug resistant (MDR). *S. aureus* (85.7%, 6/7) had the highest level of resistance to at least one antimicrobial agent followed by *S. intermedius* group (52.9%, 9/17). Similarly, *S. aureus* (42.9%, 3/7) had a higher level of MDR than *S. intermedius* group (12.5%, 2/16). One *S. intermedius* group isolate was resistant to all β-lactam antimicrobial agents tested. This isolate was also resistant to 9 out of the 15 antimicrobial agents tested. Three *S. intermedius* group isolates were resistant to both clindamycin and lincosamides. Among the *S. aureus* isolates*,* one was resistant to five antimicrobial agents and two to four antimicrobial agents (Table [4](#Tab4){ref-type="table"}).Table 3Antimicrobial resistance profile of *Staphylococcus* isolates to antimicrobial agents from samples tested at an academic veterinary laboratory, 2007--2012GroupDrugFrequencyPercent (n/N) ^b^β-lactam2628.9 (26/90) PenicillinPenicillinG1129.0 (11/27)Ampicillin1232.4 (12/26) CephalosporinCephalothin12.7 (1/37)Ceftiofur12.7 (1/37) CombinationAmoxicillin/Clavulanic acid12.7 (1/37)TetracyclineDoxycycline12.7 (1/37)Fluoroquinolone68.6 (6/70)Enrofloxacin37.9 (3/35)Orbifloxacin37.9 (3/35)Aminoglycoside43.6 (4/110)Gentamicin12.7 (1/37)Amikacin12.7 (1/37)Kanamycin25.3 (2/36)Potentiated sulfonamideSulfamethoxazole/trimethoprim410.5 (4/34)AmphenicolsChloramphenicol25.2 (2/36)LincosamidesClindamycin1334.2 (13/25)Aminoglycoside-lincosamideLincospectin1231.6 (12/26)MacrolideTylosin25.3 (2/36)^b^ = n is the number resistant, N is number tested Table 4Antimicrobial resistance patterns identified in *Staphylococcus* isolates from cat specimens tested at an academic veterinary hospital laboratory, 2007--2012Antimicrobial ResistanceMultidrug ResistanceB-Lactam resistanceResistance patternsSpeciesPercent (n/N)Percent (n/N)Percent (n/N)*S. aureus*85.7 (6/7)42.9 (3/7)0AMP (1), AMP PEN (1), AMP PEN LIN (1), AMP PEN CLI LIN (1), AMP PEN CHL LIN (1), AMP SP KAN CLI LIN (1)*S. felis*0 (0/2)00*S. intermedius* group52.9 (9/17)11.8 (2/17)5.9 (1/17)PEN (1), KAN (1), CLI LIN (3), SP LIN (1), AMP PEN SP (1), ENR LIN OR TYL (1), AMP CEF GEN PEN SP CEF KAN OR SU (1)*S. simulans*0 (0/2)00*S.* spp.90.0 (9/10)30.0 (3/10)0CLI (2), LIN (1), CHL CLI (1), AMP PEN (1), CLI LIN OR (1), AMP AMP DOX ENR PEN CLI (1), AMP PEN CLI (1), AMP ENR PEN CLI LIN TYL (1),*n* number of resistant samples, *N* number of samples tested, *AMP* ampicillin, *CEF* Ceftiofur, *ENR* Enrofloxacin, *GEN* Gentamicin, *PEN* PenicillinG, *SP* Sulpha/Trimethroprim, *CHL* Chloramphenicol, *KAN* Kanamycin, *CLI* Clindamycin/Lincomycin, *AMI* Amikacin, *DOX* Doxycycline, *LIN* Lincospectin, *ORB* Orbifloxacin, *SU* Amoxicillin/Clavulanic acid, *TYL* Tylosin

Predictors of staphylococcus infections {#Sec8}
---------------------------------------

Based on the univariable logistic model, only sex and specimen type stood out as potential predictors of *Staphylococcus* spp. infection based on a liberal α ≤ 0.20 (Table [5](#Tab5){ref-type="table"}). Thus, only these two variables were assessed in the multivariable model. In the final model only specimen type was significantly associated with staphylococcus species infection based on α ≤ 0.05. The odds of testing positive for *Staphylococcus* spp. infections were significantly higher among ear canal (*p* = 0.0002) and skin samples (*p* \< 0.0001) than urine samples (Table [6](#Tab6){ref-type="table"}). However, there was no significant differences in the odds of *Staphylococcus* spp. infection between skin and ear canal samples (Table [7](#Tab7){ref-type="table"}).Table 5Results of the univariable logistic model showing predictors of *Staphylococcus* spp. infection among cats tested at an academic veterinary hospital laboratory, 2007--2012VariableOR^a^95% CI^b^p-valueBreed Domestic Long Hair1.40.37.00.368 Domestic Short Hair0.90.42.60.707 Persian1.00.34.20.723 Siamese0.30.032.80.237 All othersRef\...Sex Female1.90.94.00.066 MaleRef\...Specimen type Ear canal swab16.14.164.2\<0.0001 Skin48.210.9213.7\<0.0001 All others7.32.026.40.003 UrineRef\...Age  \< 2 years1.10.52.20.818  \> = 2 yearsRef\...^a^Odds ratio^b^95% Confidence Interval Table 6Multivariable logistic model showing predictors of *Staphylococcus* spp. infection among cats tested at an academic veterinary hospital laboratory, 2007--2012VariableOR^1^95% CI^2^p-valueSex Female1.90.84.30.117 MaleRef\...Specimen type Ear canal swab14.83.660.50.0002 Skin52.111.3240.3\<.0001 All others8.42.330.70.001 UrineRef\... Table 7Final multivariable logistic model showing the results of changing reference categories of specimen typeVariableOR^1^95% CI^2^p-valueSpecimen type Skin3.5190.96912.780.0559 Urine0.0680.0170.2760.0002 All others0.5640.2081.5310.2611 Ear canal swabRef\... Ear canal swab0.2840.0781.0320.0559 Urine0.0190.0040.089\<.0001 All others0.160.050.5170.0022 SkinRef\... Ear canal swab1.7730.6534.810.2611 Skin6.2371.93320.1310.0022 Urine0.120.0330.4390.0014 All othersRef\...

Discussion {#Sec9}
==========

The aim of this study was to investigate the proportion of antimicrobial resistant isolates and resistance patterns of *Staphylococcus* spp. isolates from clinical samples obtained from cats admitted to a veterinary academic hospital in South Africa. The proportion of *Staphylococcus* spp. isolated from cat samples in this study was relatively low (17.6%). This is not directly comparable to findings from other previous studies on cats due to differences in isolation methods (use of enrichment media in particular), and differences in study designs. In the current study, we investigated *Staphylococcus* infections in hospitalised clinical cases only. However, the majority of similar published studies of *Staphylococcus* in cats have largely focused on methicillin resistance rather than *Staphylococcus* infections in general. In addition, past studies have focused on carriage rather than infections \[[@CR8], [@CR17]\].

Similar to findings from other studies \[[@CR8], [@CR17]\], in this study we observed that skin and ear canal samples had significantly higher odds of testing positive for *Staphylococcus* spp. than other samples. These results seem to suggest that *Staphylococcus* spp. are a major cause of skin related infections in cats \[[@CR18]--[@CR20]\]. Although there tended to be a higher proportion of *Staphylococcus* spp. isolated from the domestic short hair breeds, the final model indicated no significant association between breed and odds of *Staphylococcus* spp. infection. However, the lack of significant association might be due to small sample size involved in this study. It is worth noting that, there is evidence that certain diseases are more common in certain breeds of cats and we suspect that this might be the case with *Staphylococcus* infections \[[@CR17], [@CR21]\].

Consistent with other studies \[[@CR3], [@CR5], [@CR17], [@CR19]\], we observed a higher percentage of CoPS than CoNS. This is mainly due to the observed higher percentage of *S. intermedius* group, which are CoPS, isolated in this study. On the contrary, Abraham et al. \[[@CR7]\] reported nearly equal proportions of *S. aureus* and *S. pseudintermedius* isolates from asymptomatic cats. Consistent with our study, a Brazilian study by Lilenbaum et al. \[[@CR8]\] reported a higher percentage of *S. intermedius* group (*S. pseudintermedius*) in cats compared to other *Staphylococcus* species. This may be related to the fact that SIG especially *S. pseudintermedius* is well adapted to the skin surface of dogs and cats than *S. aureus* \[[@CR22]--[@CR25]\].

The observed higher percentage of resistance towards β-lactam and lincosamide antimicrobial agents among the *Staphylococcus* isolates in cats has previously been reported \[[@CR6], [@CR8], [@CR23]\]. Of particular concern is one *S. intermedius* group isolate that was resistant to all β-lactam antimicrobial agents tested in this study. Moreover, MRSA have an intrinsic resistance to β-lactams by virtue of newly acquired low-affinity penicillin-binding protein 2A (PBP2A). Therefore, it is possible that this isolate was MRSA \[[@CR26], [@CR27]\]. Unforunately, we could not assess this since the lab that supplied the data used in this study did not test for methicillin resistance. Almost 16 % (15.8%) of *Staphylococcus* isolates in this study were MDR. This is close to the 14.8% reported by Gandolfi-Decristophoris et al. \[[@CR23]\] in Switzerland.

Since this is a retrospective study, these findings should be interpreted with caution. The history of previous use of antimicrobial agents was not included in the analysis and this could have affected the recovery rates of *Staphylococcus* species. The study also suffers from low samples size which impacted the precision of some of the estimates. Nonetheless, the results provide a useful preliminary indication of the burden and antimicrobial resistance patterns of *Staphylococcus* spp. infections in cats presented to the academic veterinary hospital in South Africa.

Conclusions {#Sec10}
===========

As has been observed in other studies, this study suggests that *S. intermedius* group is the most common cause of skin infections in cats investigated in this study. It also suggests that antimicrobial resistance is not so wide spread among cats presented at the veterinary academic hospital in South Africa. Considering the risk of cross-transmission of resistant organisms between cats and humans, the levels of resistance to β-lactams is of great concern from both a public health and animal health point of view. However, given the limited scope of this study, there is need for larger and more detailed primary base studies to specifically assess the extent of antimicrobial resistant infections in cats in South Africa and their role in the spread of antimicrobial drug resistance to humans.
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